Replimune Group, Inc. (REPL) Misses Q4 EPS by 235c

Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($3.07), $2.35 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Franklin BSP Realty Trust (FBRT) Reiterated at Market Outperform by Citizens
• Jefferies Starts China Oilfield Services (A-Shares) (601808:CH) at Buy
• KB Home (KBH) Tops Q3 EPS by 16c